4.6 Article

A longitudinal study characterising a large adult primary ciliary dyskinesia population

期刊

EUROPEAN RESPIRATORY JOURNAL
卷 48, 期 2, 页码 441-450

出版社

EUROPEAN RESPIRATORY SOC JOURNALS LTD
DOI: 10.1183/13993003.00209-2016

关键词

-

资金

  1. National Institute for Health Research (NIHR) Respiratory Disease Biomedical Research Unit at the Royal Brompton
  2. Imperial College London
  3. Harefield NHS Foundation Trust

向作者/读者索取更多资源

Primary ciliary dyskinesia (PCD) in adults has not been well described. In this retrospective observational study we aimed to characterise a large adult population and identify features associated with disease progression. We retrospectively analysed 151 adult patients at a single tertiary centre at baseline and longitudinally for a median of 7 years. We found significant variation in age at diagnosis (median 23.5 years; range <1-72 years). Older age at diagnosis was associated with impaired baseline forced expiratory volume in 1 s (FEV1) (r=-0.30, p=0.01) and increased Pseudomonas aeruginosa colonisation (difference in medians 17 years (95% CI 4.5-20 years); p=0.002). Lung function decline was estimated at FEV1 decline of 0.49% predicted per year. Lung function decline was associated with ciliary ultrastructure, with microtubular defect patients having the greatest decline (p=0.04). High-resolution computed tomography (HRCT) scores of severity of bronchial wall dilatation (p<0.001) and extent of bronchiectasis (p=0.03) additionally showed evidence of modifying FEV1 decline with age. Our study reveals that a large proportion of adult PCD patients are diagnosed late, with impaired FEV1 and increased P. aeruginosa colonisation. Increased disease burden on HRCT and ciliary ultrastructure may predict progressive lung function decline. This study characterises a large adult PCD population, identifies features associated with disease progression and highlights the need for prospective trials to determine whether early diagnosis of high-risk subgroups alongside optimal management can modify disease progression.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据